[Retroperitoneal renal hemorrhage: experience of our dialysis center]

G Ital Nefrol. 2018 Dec;35(6):2018-vol6.
[Article in Italian]

Abstract

The aging of the uremic population, the increasingly common use of anticoagulants, antiplatelet agents e heparin, during hemodialysis, can expose our patients to a greatest risk of bleeding. Spontaneous retroperitoneal hematomas are a fairly rare and potentially fatal condition. We describe 5 clinical cases of retroperitoneal hemorrhage that we observed during 10 years in our department, focusing on modalities of symptom onset, clinical-laboratory picture and treatment modalities.

Keywords: Retroperitoneal hemorrhage; hemodialysis.

MeSH terms

  • Adult
  • Aged
  • Anemia / etiology
  • Anticoagulants / adverse effects
  • Comorbidity
  • Emergencies
  • Female
  • Hematoma / diagnostic imaging
  • Hematoma / epidemiology*
  • Hematoma / etiology
  • Hematoma / therapy
  • Humans
  • Lupus Nephritis / complications
  • Lupus Nephritis / therapy
  • Male
  • Population Dynamics
  • Recurrence
  • Renal Dialysis*
  • Retroperitoneal Space
  • Tomography, X-Ray Computed
  • Ultrasonography
  • Uremia / complications
  • Uremia / therapy

Substances

  • Anticoagulants